CATALYST PHARMACEUTICAL PARTNERS, INC. 4
4 · CATALYST PHARMACEUTICAL PARTNERS, INC. · Filed Oct 6, 2014
Insider Transaction Report
Form 4
HUCKEL HUBERT E MD
Director10% Owner
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2014-10-02$0.90/sh+30,000$27,000→ 1,334,134 total - Exercise/Conversion
Options to purchase common stock
2014-10-02−30,000→ 639,804 totalExercise: $0.90From: 2009-10-20Exp: 2014-10-20→ Common Stock (30,000 underlying) - Tax Payment
Common stock, par value $0.001 per share
2014-10-02−9,964→ 1,324,170 total
Footnotes (1)
- [F1]Holder exercised 30,000 options at $0.90 per share via cashless exercise and was issued 20,036 shares based on the October 2, 2014 closing price of $2.71 per share.